Cargando…

Remote-controlled cholangiography injection device: first clinical study in China

BACKGROUND: X-ray cholangiography is of great value in the imaging of biliary tract diseases; however, occupational radiation exposure is unavoidable. Moreover, clinicians must manually inject the contrast dye, which may result in a relatively high incidence of adverse reactions due to unstable inje...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Huan, Shan, Li-yu, Ma, Tao, Wang, Yue, Feng, Zhe, Dong, Ding-Hui, Lv, Yi, Zhu, Hao-Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742431/
https://www.ncbi.nlm.nih.gov/pubmed/34996384
http://dx.doi.org/10.1186/s12876-021-02087-8
_version_ 1784629711680307200
author Chen, Huan
Shan, Li-yu
Ma, Tao
Wang, Yue
Feng, Zhe
Dong, Ding-Hui
Lv, Yi
Zhu, Hao-Yang
author_facet Chen, Huan
Shan, Li-yu
Ma, Tao
Wang, Yue
Feng, Zhe
Dong, Ding-Hui
Lv, Yi
Zhu, Hao-Yang
author_sort Chen, Huan
collection PubMed
description BACKGROUND: X-ray cholangiography is of great value in the imaging of biliary tract diseases; however, occupational radiation exposure is unavoidable. Moreover, clinicians must manually inject the contrast dye, which may result in a relatively high incidence of adverse reactions due to unstable injection pressure. Thus, there is a need to develop a novel remote-controlled cholangiography injection device. METHODS: Patients with external biliary drainage requiring cholangiography were included. A remote-controlled injection device was developed with three major components: an injection pump, a pressure sensor, and a wireless remote-control panel. Image quality, adverse reactions, and radiation dose were evaluated. RESULTS: Different kinds of X-ray cholangiography were successfully and smoothly performed using this remote-controlled injection device in all patients. The incidence of adverse reactions in the device group was significantly lower than that in the manual group (4.17% vs. 13.9%, P = 0.001), and increasing the injection pressure increased the incidence of adverse reactions. In addition, the device helped operators avoid ionizing radiation completely. CONCLUSIONS: With good control of injection pressure (within 10 kPa), the remote-controlled cholangiography injection device could replace the need for the doctor to inject contrast agent with good security and effectivity. It is expected to be submitted for clinical application.
format Online
Article
Text
id pubmed-8742431
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-87424312022-01-10 Remote-controlled cholangiography injection device: first clinical study in China Chen, Huan Shan, Li-yu Ma, Tao Wang, Yue Feng, Zhe Dong, Ding-Hui Lv, Yi Zhu, Hao-Yang BMC Gastroenterol Research BACKGROUND: X-ray cholangiography is of great value in the imaging of biliary tract diseases; however, occupational radiation exposure is unavoidable. Moreover, clinicians must manually inject the contrast dye, which may result in a relatively high incidence of adverse reactions due to unstable injection pressure. Thus, there is a need to develop a novel remote-controlled cholangiography injection device. METHODS: Patients with external biliary drainage requiring cholangiography were included. A remote-controlled injection device was developed with three major components: an injection pump, a pressure sensor, and a wireless remote-control panel. Image quality, adverse reactions, and radiation dose were evaluated. RESULTS: Different kinds of X-ray cholangiography were successfully and smoothly performed using this remote-controlled injection device in all patients. The incidence of adverse reactions in the device group was significantly lower than that in the manual group (4.17% vs. 13.9%, P = 0.001), and increasing the injection pressure increased the incidence of adverse reactions. In addition, the device helped operators avoid ionizing radiation completely. CONCLUSIONS: With good control of injection pressure (within 10 kPa), the remote-controlled cholangiography injection device could replace the need for the doctor to inject contrast agent with good security and effectivity. It is expected to be submitted for clinical application. BioMed Central 2022-01-07 /pmc/articles/PMC8742431/ /pubmed/34996384 http://dx.doi.org/10.1186/s12876-021-02087-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Chen, Huan
Shan, Li-yu
Ma, Tao
Wang, Yue
Feng, Zhe
Dong, Ding-Hui
Lv, Yi
Zhu, Hao-Yang
Remote-controlled cholangiography injection device: first clinical study in China
title Remote-controlled cholangiography injection device: first clinical study in China
title_full Remote-controlled cholangiography injection device: first clinical study in China
title_fullStr Remote-controlled cholangiography injection device: first clinical study in China
title_full_unstemmed Remote-controlled cholangiography injection device: first clinical study in China
title_short Remote-controlled cholangiography injection device: first clinical study in China
title_sort remote-controlled cholangiography injection device: first clinical study in china
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742431/
https://www.ncbi.nlm.nih.gov/pubmed/34996384
http://dx.doi.org/10.1186/s12876-021-02087-8
work_keys_str_mv AT chenhuan remotecontrolledcholangiographyinjectiondevicefirstclinicalstudyinchina
AT shanliyu remotecontrolledcholangiographyinjectiondevicefirstclinicalstudyinchina
AT matao remotecontrolledcholangiographyinjectiondevicefirstclinicalstudyinchina
AT wangyue remotecontrolledcholangiographyinjectiondevicefirstclinicalstudyinchina
AT fengzhe remotecontrolledcholangiographyinjectiondevicefirstclinicalstudyinchina
AT dongdinghui remotecontrolledcholangiographyinjectiondevicefirstclinicalstudyinchina
AT lvyi remotecontrolledcholangiographyinjectiondevicefirstclinicalstudyinchina
AT zhuhaoyang remotecontrolledcholangiographyinjectiondevicefirstclinicalstudyinchina